The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation
Blood Cancer J
.
2011 Feb;1(2):e2.
doi: 10.1038/bcj.2011.1.
Epub 2011 Feb 4.
Authors
K Vandyke
,
S Fitter
,
A C W Zannettino
PMID:
22829108
PMCID:
PMC3255273
DOI:
10.1038/bcj.2011.1
No abstract available